https://www.insurerbrain.com/w/index.php?action=history&feed=atom&title=Definition%3AEuropean_Commission_merger_controlDefinition:European Commission merger control - Revision history2026-04-29T10:19:23ZRevision history for this page on the wikiMediaWiki 1.43.8https://www.insurerbrain.com/w/index.php?title=Definition:European_Commission_merger_control&diff=10158&oldid=prevPlumBot: Bot: Creating new article from JSON2026-03-11T06:58:33Z<p>Bot: Creating new article from JSON</p>
<p><b>New page</b></p><div>🏢 '''European Commission merger control''' is the administrative process through which the Commission's Directorate-General for Competition (DG COMP) investigates and decides on concentrations notified under the [[Definition:EU Merger Regulation | EU Merger Regulation]], a process that regularly encompasses major insurance-sector transactions such as carrier-to-carrier mergers, [[Definition:Reinsurance | reinsurer]] consolidations, [[Definition:Private equity | private equity]] roll-ups of [[Definition:Managing general agent (MGA) | MGA]] platforms, and [[Definition:Insurance broker | brokerage]] combinations with pan-European footprints. The Commission acts as a one-stop-shop for deals that meet EU-wide turnover thresholds, sparing parties from filing separately in each member state.<br />
<br />
⚙️ After notification, the Commission conducts a Phase I review — typically 25 working days — to determine whether the transaction raises serious doubts about its compatibility with the internal market. If concerns emerge, the case moves to an in-depth Phase II investigation lasting up to 90 additional working days, extendable if remedies are offered. In insurance matters, DG COMP defines relevant markets by product segment ([[Definition:Property and casualty insurance | property and casualty]], [[Definition:Life insurance | life]], [[Definition:Health insurance | health]], or specific sub-lines like [[Definition:Marine insurance | marine]]) and by geography, which can range from national to EEA-wide depending on evidence of cross-border purchasing patterns and [[Definition:Premium | premium]] flows. The Commission may accept commitments such as portfolio [[Definition:Divestiture | divestitures]], waiver of exclusivity in [[Definition:Insurance distribution | distribution]] agreements, or structural separation of overlapping business units.<br />
<br />
💡 Insurance-specific features of European Commission merger control distinguish it from its U.S. counterpart. [[Definition:Solvency II | Solvency II]] prudential supervision runs in parallel, meaning that even after DG COMP clears a deal on competition grounds, national [[Definition:Insurance regulator | insurance supervisors]] must separately approve changes of control — and their assessment criteria focus on solvency, governance, and [[Definition:Policyholder | policyholder]] protection rather than competitive effects. Dealmakers who treat the competition clearance as the finish line risk delays from prudential authorities in multiple jurisdictions. Coordinating both workstreams from day one is a hallmark of well-executed [[Definition:Cross-border M&A (insurance) | cross-border insurance M&A]].<br />
<br />
'''Related concepts:'''<br />
{{Div col|colwidth=20em}}<br />
* [[Definition:EU Merger Regulation]]<br />
* [[Definition:Competition and Markets Authority (CMA) review]]<br />
* [[Definition:Solvency II]]<br />
* [[Definition:Cross-border M&A (insurance)]]<br />
* [[Definition:Market concentration (insurance)]]<br />
* [[Definition:Herfindahl-Hirschman Index (HHI)]]<br />
{{Div col end}}</div>PlumBot